维普中文期刊产品整合服务
18篇 您的检索式:作者名="Wenandy L"
    题名 作者 年代 出处 被引量
1RhoC a new target for therapeutic vaccination against metastatic cancer 显示文摘Wenandy L Sφrensen RB Svane IM 2008Cancer Immunol Immunother2008,27,8:1
2Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4~ T cells by the microRNA miR-125b 显示文摘Rossi RL Rossetti G Wenandy L 2011Nat Immuuol2011,12,8:1
3Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b 显示文摘Rossi RL Rossetti G Wenandy L 2011Nat Immunol2011,12,8:1
4Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4 + T cells by the microRNA miR-125b 显示文摘Rossi RL Rossetti G Wenandy L 2011Nat Immunol2011,12,8:1
5Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer显示文摘Junker N Andersen MH Wenandy L 2011Cytotherapy2011,13,7:1
6The immunogenicity of the hTERT540 -548 peptide in cancer显示文摘Wenandy L Sorensen RB Sengelov L 2008Clin Cancer Res2008,14,1:1
7The immunogenicity of the hTERT540-548 peptide in cancer显示文摘Wenandy L Sφrensen RB Sengelφv L 2008Clin Cancer Res2008,14,1:1
8Therapeuticdendritic cell vaccination of patients with metastatic renal cellcarcinoma:a clinical phase 1/2trial显示文摘Berntsen A Trepiakas R Wenandy L 2008J Immunother2008,31,8:1
9Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+T cells by the microRNA miR-125b显示文摘Rossi RL Rossetti G Wenandy L Curti S Ripamonti A Bonnal RJ 0,,:1
10Ther apeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial显示文摘Berntsen A Trepiakas R Wenandy L 2008J Immunother2008,31,8:1
11Therapeutic dendrit- ic cell vaccination of patients with metastatic renal cell carcinoma : A clinical phase I / ]1 trial 显示文摘Berntsen A Trepiakas R Wenandy L 2008J Imrnunotber2008,31,8:1
12Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial 显示文摘Bemtsen A Trepiakas R Wenandy L 2008J Immunother2008,31,8:1
13Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma:a clinical phase 1/2 trial显示文摘BERNTSEN A TREPIAKAS R WENANDY L 2008J Immunother2008,31,8:1
14The immunogenicity of the hTERT540-548 peptide in cancer 显示文摘Wenandy L So rensen RB Sengelov L 2008Clin Cancer Res2008,14,1:1
15The immunogenicity of the hTERT540-548 peptide in cancer 显示文摘Wenandy L Sorensen RB Sengelov L 2008Clin Cancer Res2008,14,1:1
16The immunogenicity of the hTERT540-548 peptide in cancer显示文摘WENANDY L SORENSEN R B SENGELOV L 2008Clin Cancer Res2008,14,:1
17Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma:a clinical phase 1/2 trial显示文摘Berntsen A Trepiakas R Wenandy L 2008J Immunother2008,31,8:1
18Distinct microRNA signa- tures in human lymphocyte subsets and enforcement of the naive state in CIM + T cells by the microRNA miR,125b 显示文摘Rossi R L Rossetti G Wenandy L 2011Nat Immu- nol2011,12,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费